Daily Report for () on 16-Oct-2025

Report
Parameters To Be Monitored

Action

TAB. DILZEM +1(180)
ORAL
TAB. DILZEM +1(180)
ORAL
CAP. LIOFEN +1(30mg)
ORAL
TAB. LOSAR H1 +1(50mg)
ORAL
TAB. LOSAR H1 +1(50mg)
ORAL
TAB. DILZEM +1(180mg)
ORAL
TAB. ZOLPIDEM TARTRATE +1(10mg)
ORAL
TAB. Z +1(10mg)
ORAL
TAB TIDEPLUS +1(20mg)
ORAL
TAB CIDMAS +1(10mg)
ORAL
TAB IVABRAD +1(5mg)
ORAL
TAB MONTAK AB +1(10mg)
ORAL
TAB FEBNTAZ +1(80)
ORAL
TAB FIRANOIN +1(10mg)
ORAL
SYP CREAMFFINI PLUS +1(3ml)
ORAL
DULION NEBULIZATION +1(1stf )
NASAL CAVITY
TAB PANTOP +1(40mg)
ORAL
TAB TIDEPLUS +1(20mg)
ORAL
TAB IVABRAD +1(5mg)
ORAL
TAB MONTAK AB +1(10mg)
ORAL
TAB FEBRATAZ +1(80)
ORAL
TAB VELTAM PLUS +1(20mg)
ORAL
SYP CREAMFFINI PLUS +1(3mi)
ORAL
DULION NEBULIZATION +1(1stf )
NASAL CAVITY
TAB PANTOP +1(40mg)
ORAL
TAB-TELMA +1(40MG)
ORAL
TAB-AMLOGARD +1(10 MG)
ORAL
TAB- AMIFUR +1(40MG)
ORAL
CAP- D-WELL AQ +1(1cap)
ORAL
TAB- VIT. C +1(1 tab)
ORAL
TAB CIDMAS +2(10mg)
ORAL
TAB IVABRAD +2(5mg)
ORAL
TAB TIDEPLUS +2(20mg)
ORAL
TAB IVABRAD +2(5mg)
ORAL